FOIA Requests and Litigation Revealing Data Hidden by Big Pharma
Segment # 087
The basic assumption is that our elected representatives work for us. That reality has certainly has been tested both with the legitimacy of our elections and the innate ability of a politician to promise one thing and then do another. The one tool remaining for any US citizen is our court system which rules on the constitutional questions our elected members swore to uphold. Ok maybe a little kabuki theater here; but legislation did create FOIA – the Freedom of Information Act which entitles you to be informed in a democratic system what your government is actually doing.
FOIA is revealing secrets that our government has been trying to hide. And this is only the beginning. See below some of the things that have been made public as a result of lawyers who have successful used FOIA.
FOIA.gov – “The basic function of the Freedom of Information Act is to ensure informed citizens, vital to the functioning of a democratic society. This site can help you determine if filing a FOIA request is the best option for you and help you create your request when you’re ready.”Any U.S. citizen may file a FOIA request seeking information from a governmental agency. This option has been used to uncover information not released and potentially hidden by government agencies.
When the FOIA system breaks down litigation through our federal system resolves disputes.
https://icandecide.org/vaccine-safety-debate/
The Informed Consent Action Network (ICAN at icandecide.org) has been leading the attempts to seek the release of censored information to the U.S. public. Listed below are some of ICAN efforts in the area of vaccine safety. ICAN is part of TheHighwire.com that provides weekly updates on topics of general interest focusing on health issues.
None of these cases have been covered by the Media or Big Tech. Most of these cases greatly impact the lives of not only domestically for Americans but also internationally for the world population. It is perverse and criminal corruption that has blocked these issues from being debated by medical experts and scientists.
AstraZeneca study finds vector DNA in the sciatic nerve, bone marrow, liver, lungs, and spleen of vaccinated mice.
Because AstraZeneca’s COVID-19 vaccine is not licensed in the United States, all documents within the FDA’s possession concerning this vaccine are exempt from disclosure. This means that anyone who received an AstraZeneca COVID-19 vaccine cannot – and might not ever be able to – access any of the data concerning the vaccine from the US government.
Not satisfied by this complete lack of transparency, ICAN, through its attorneys, submitted an information request to the United Kingdom’s FDA equivalent – the Medicines and Healthcare Products Registry Agency (MHRA) -- in April 2022 seeking information relating to its authorization of the AstraZeneca COVID-19 vaccine, as well as that relating to its authorization of the Janssen, Moderna, and Pfizer COVID-19 vaccines.
MHRA’s initial response was to threaten to deny ICAN’s request but, after ICAN pushed back and, in the case of the AstraZeneca vaccine, narrowed the scope of the request to seven specific items related to safety testing, MHRA dropped its objection. MHRA recently provided 166 pages of records containing the studies MHRA relied on to authorize AstraZeneca’s COVID-19 vaccine.
One of these studies investigated biodistribution of the AstraZeneca vaccine, meaning where it goes in the body after injection, in mice. This study revealed that the viral vector DNA did not remain localized in the injection site but instead migrated to other organs. Disturbingly, the study found vector DNA in the sciatic nerves, bone marrow, livers, lungs, and spleens of the mice following vaccination.
The study documents further revealed that, in early 2021, AstraZeneca was forced to amend its data sheet for the vaccine after concluding that there may have been a causal association between the vaccine and serious hypersensitivity including anaphylaxis.
Another perhaps unsurprising revelation was the inclusion of disclaimer that a number of vulnerable populations, such as pregnant and lactating women and immunocompromised persons, were excluded from pre-market human safety studies. In its Marketing Authorization Application, AstraZeneca stated that because these populations were excluded from the studies, the safety of the vaccine in these groups was unknown. This also led the UK’s Joint Committee on Vaccination and Immunization (JCVI) to recommend against the AstraZeneca vaccine for pregnant women – a sentiment that was echoed in the UK’s vaccination schedule guide, commonly referred to as the “Green Book.”
A final shocking revelation in the documents was the heavily redacted discussion of two individuals who developed serious immune-mediated neurological demyelinating conditions following vaccination. Although it states there was “no evidence suggesting a causal relationship” between the vaccine and these events, the UK’s clinical overview conceded that “vaccinations could be associated with immune-mediated neurological conditions” and therefore these adverse events were included as an important potential risk in the vaccine’s risk management plan.
In the coming weeks, MHRA is expected to produce additional documents regarding its authorization of the other COVID-19 vaccines.
In the meantime, you can read about other related work ICAN has done concerning COVID-19 vaccine safety data:
ICAN OBTAINS CRUCIAL PFIZER VACCINE LOT, DOSE, AND DISTRIBUTION INFORMATION
COVID-19 VACCINE MANUFACTURERS FAIL TO PROPERLY INVESTIGATE ADVERSE EVENTS REPORTS
ICAN DEMANDS ANSWERS ABOUT DEATH DISCREPANCIES IN PFIZER’S CLINICAL TRIAL
PFIZER’S YEARS-LONG COZY RELATIONSHIP WITH CDC OFFICIAL REVEALED
FDA PLAYING GAMES WITH THE PUBLIC REGARDING COVID-19 VACCINES
To share this legal update, please use this link: https://icandecide.org/press-release/ican-obtains-disturbing-information-about-astrazenecas-covid-19-vaccine-from-the-uk-equivalent-of-the-fda/
Employment Opportunity: A law firm that regularly represents ICAN has an opening for (i) an attorney with litigation and/or civil rights experience; and (ii) an attorney with class action experience. If interested, please send a resume, a short cover letter, and 2-4 writing samples to jenna@icandecide.org
